Christina Brigham, | |
3900 W Brown Deer Rd, Ste 200, Brown Deer, WI 53209-1220 | |
(414) 540-2170 | |
(414) 540-2171 |
Full Name | Christina Brigham |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 12 Years |
Location | 3900 W Brown Deer Rd, Brown Deer, Wisconsin |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467796433 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 8252-123 (Wisconsin) | Primary |
101YA0400X | Counselor - Addiction (substance Use Disorder) | 15949-131 (Wisconsin) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
New Frontiers Psychiatric Sc | 7416201058 | 10 |
News Archive
The suspicion that drinking soy milk or soy-based formula is a factor in children developing a peanut allergy has been dispelled by Australian scientists.
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cinacalcet HCl Tablets 30, 60 & 90 mg.
› Verified 5 days ago
Entity Name | Elmbrook Family Counseling Center Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831211309 PECOS PAC ID: 2860396728 Enrollment ID: O20031121000586 |
News Archive
The suspicion that drinking soy milk or soy-based formula is a factor in children developing a peanut allergy has been dispelled by Australian scientists.
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cinacalcet HCl Tablets 30, 60 & 90 mg.
› Verified 5 days ago
Entity Name | Shorehaven Behavioral Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598800740 PECOS PAC ID: 0143324954 Enrollment ID: O20070404000380 |
News Archive
The suspicion that drinking soy milk or soy-based formula is a factor in children developing a peanut allergy has been dispelled by Australian scientists.
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cinacalcet HCl Tablets 30, 60 & 90 mg.
› Verified 5 days ago
Entity Name | New Frontiers Psychiatric Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003390394 PECOS PAC ID: 7416201058 Enrollment ID: O20181116001317 |
News Archive
The suspicion that drinking soy milk or soy-based formula is a factor in children developing a peanut allergy has been dispelled by Australian scientists.
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cinacalcet HCl Tablets 30, 60 & 90 mg.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Christina Brigham, 3900 W Brown Deer Rd, Ste 200, Brown Deer, WI 53209-1220 Ph: (414) 540-2170 | Christina Brigham, 3900 W Brown Deer Rd, Ste 200, Brown Deer, WI 53209-1220 Ph: (414) 540-2170 |
News Archive
The suspicion that drinking soy milk or soy-based formula is a factor in children developing a peanut allergy has been dispelled by Australian scientists.
Echo Therapeutics, Inc., a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, today announced that it received a notice of allowance for U.S. Patent Application No.11/275,038, "System and Method for Continuous Non-Invasive Glucose Monitoring," for the Symphony tCGM System.
An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Cinacalcet HCl Tablets 30, 60 & 90 mg.
› Verified 5 days ago
Melissa Koff, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170 | |
Dr. Jose B. Torres, PHD. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd, Brown Deer, WI 53209 Phone: 414-540-2170 Fax: 414-540-2171 | |
Susell Zarza-o'neill, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd Ste 200, Brown Deer, WI 53209 Phone: 414-540-2170 Fax: 414-540-2171 | |
Jennifer Kramer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd, Suite 200, Brown Deer, WI 53209 Phone: 414-540-7120 Fax: 414-540-2171 | |
Michael B Seeley, MSW, LCSW, CADC Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 8200 W Brown Deer Rd, Suite 300a, Brown Deer, WI 53223 Phone: 414-362-8147 Fax: 414-362-7198 | |
Annette E Madison, MSW, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6051 W Brown Deer Rd, Suite 106, Brown Deer, WI 53223 Phone: 414-354-1030 Fax: 414-354-7584 | |
Chelsea R. Gilbertson, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3900 W Brown Deer Rd, Suite 200, Brown Deer, WI 53209 Phone: 414-540-2170 Fax: 414-540-2171 |